Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Chronic Heart Failure

Free Subscription Articles published in J Cardiovasc Pharmacol Retrieve available abstracts of 17 articles: HTML format Text format

Single Articles

July 2019
1. BONAVENTURA A, Wohlford GF, Vecchie A, Van Tassel BW, et al
   In-Hospital Initiation of Sacubitril/Valsartan: A New PARADIGM for Acute Decompensated Heart Failure?
   J Cardiovasc Pharmacol. 2019;74:1-3.
   PubMed     Text format    
   
   
   June 2019
2. TOYODA S, Arikawa T, Inami S, Nishikawa R, et al
   Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
   J Cardiovasc Pharmacol. 2019;73:365-372.
   PubMed     Text format     Abstract available
   
   
   March 2019
3. PINTO G, Tondi L, Gemma M, De Marco A, et al
   Real Life Indications to Sacubitril/Valsartan Treatment in Patients with Chronic Systolic Heart Failure.
   J Cardiovasc Pharmacol. 2019 Mar 6. doi: 10.1097/FJC.0000000000000665.
   PubMed     Text format     Abstract available
   
   
   December 2018
4. DU AX, Westerhout CM, McAlister FA, Shanks M, et al
   The Titration and Tolerability of Sacubitril/Valsartan for Patients with Heart Failure in Clinical Practice.
   J Cardiovasc Pharmacol. 2018 Dec 10. doi: 10.1097/FJC.0000000000000643.
   PubMed     Text format     Abstract available
   
   
   November 2018
5. LEENEN FH, Ahmad M, Marc Y, Llorens-Cortes C, et al
   Specific Inhibition of Brain Angiotensin III formation as a new strategy for prevention of heart failure after myocardial infarction.
   J Cardiovasc Pharmacol. 2018 Nov 30. doi: 10.1097/FJC.0000000000000638.
   PubMed     Text format     Abstract available
   
   
   May 2018
6. VERRIER RL
   Ivabradine's Pleiotropic Profile: Can It Protect against Doxorubicin-Induced Heart Failure?
   J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000597.
   PubMed     Text format    
   
   
   
7. CHANG PC, Lu YY, Lee HL, Lin SF, et al
   Paradoxical Effects of Sodium-Calcium Exchanger Inhibition on Torsade de Pointes and Early Afterdepolarization in a Heart Failure Rabbit Model.
   J Cardiovasc Pharmacol. 2018 May 3. doi: 10.1097/FJC.0000000000000598.
   PubMed     Text format     Abstract available
   
   
   April 2018
8. SALAH EM, Bastacky SI, Jackson EK, Tofovic SP, et al
   Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
   J Cardiovasc Pharmacol. 2018;71:205-214.
   PubMed     Text format     Abstract available
   
   
   November 2017
9. COLE-JEFFREY CT, Pepine CJ, Katovich MJ, Grant MB, et al
   Beneficial Effects Of Angiotensin-(1-7) On Cd34 + Cells From Heart Failure Patients.
   J Cardiovasc Pharmacol. 2017 Nov 8. doi: 10.1097/FJC.0000000000000556.
   PubMed     Text format     Abstract available
   
   
   September 2017
10. ABBATE A, Van Tassell BW
    Levosimendan in advanced heart failure: where do we stand?
    J Cardiovasc Pharmacol. 2017 Sep 25. doi: 10.1097/FJC.0000000000000539.
    PubMed     Text format    
    
    
    August 2017
11. ALTENBERGER J, Gustafsson F, Harjola VP, Karason K, et al
    Levosimendan in acute and advanced heart failure: an appraisal of the clinical database and evaluation of its therapeutic applications.
    J Cardiovasc Pharmacol. 2017 Aug 15. doi: 10.1097/FJC.0000000000000533.
    PubMed     Text format     Abstract available
    
    
    June 2017
12. HANSEN MS, Andersen A, Holmboe S, Schultz JG, et al
    Levosimendan prevents and reverts right ventricular failure in experimental pulmonary arterial hypertension.
    J Cardiovasc Pharmacol. 2017 Jun 19. doi: 10.1097/FJC.0000000000000508.
    PubMed     Text format     Abstract available
    
    
    April 2017
13. BEI WJ, Wang K, Li HL, Lin KY, et al
    Safe Hydration Volume to Prevent Contrast-Induced Acute Kidney Injury and Worsening Heart Failure in Patients with Heart Failure and Preserved Ejection Fraction Following Cardiac Catheterization.
    J Cardiovasc Pharmacol. 2017 Apr 27. doi: 10.1097/FJC.0000000000000502.
    PubMed     Text format     Abstract available
    
    
    February 2017
14. KOLPAKOV MA, Tilley DG, Sabri A
    Galphaq Signaling in the Regulation of Autophagy and Heart Failure.
    J Cardiovasc Pharmacol. 2017 Feb 3. doi: 10.1097/FJC.0000000000000471.
    PubMed     Text format    
    
    
    
15. HU J, Sharifi-Sanjani M, Tofovic SP
    Nitrite Prevents Right Ventricular Failure and Remodeling Induced by Pulmonary Artery Banding.
    J Cardiovasc Pharmacol. 2017;69:93-100.
    PubMed     Text format     Abstract available
    
    
    January 2017
16. HOLMBOE S, Andersen A, Johnsen J, Nielsen JM, et al
    Inotropic Effects of Prostacyclins on the Right Ventricle Are Abolished in Isolated Rat Hearts With Right-Ventricular Hypertrophy and Failure.
    J Cardiovasc Pharmacol. 2017;69:1-12.
    PubMed     Text format     Abstract available
    
    
    April 2016
17. HILLGAARD TK, Andersen A, Andersen S, Vildbrad MD, et al
    Levosimendan Prevents Pressure-Overload-induced Right Ventricular Failure.
    J Cardiovasc Pharmacol. 2016;67:275-82.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: